Report Overview
The EU Gastroesophageal Reflux Disease Drugs and Devices market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 0.93% during the forecast period
Gastroesophageal reflux disease(GERD) is a condition in which reflux of gastric contents into the esophagus produces frequent or severe symptoms that negatively affect the individual's quality of life or result in damage to esophagus, pharynx, or the respiratory tract
Market Drivers
The chances of GERD among patients coming for diagnosis at least once per week is in the range of 8.825.9 % in Europe. Associations like European Medicines Agency (EMA), Federal Institute for Drugs and Medical Devices, German Society of Gastroenterology, Digestive and Metabolic Diseases, etc. are the key regulatory bodies that are spreading awareness about GERD and other acid-associated maladies. This level of awareness is promoting the growth of the said market in Europe
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.